PhRMA submitted comments this week in response to the Department of Health & Human Services’ (HHS) 2023 Notice of Benefit and Payment Parameters (NBPP) proposed rule. As outlined in our comments, PhRMA supports many of the policies in the proposed rule that would help improve the affordability of and access to health care, particularly among disadvantaged populations, including the following:
